FARMA TEKNOLOJİ HABER
Five keys to reducing time-to-market 2012-06-27

With development times measured in years, increasing costs represent a major challenge confronting pharmaceutical and biotechnology companies. As a result, reducing time-to-market is an essential component in any business strategy, particularly when the end of patent protection is considered. One solution is to partner with a contract manufacturer that provides intelligent concepts and the proper experience, not only with respect to the production itself, but also with regulatory authorities. Planning early on is crucial to speeding up the time-to-market process.

KAYNAK: In-Pharma

 

TARİH BAŞLIK KAYNAK
2012-06-24 Patent for chewable dosage manufacturing process In-Pharma
2012-06-27 Five keys to reducing time-to-market In-Pharma
2012-06-27 Pharmaceutical Outsourcing - key success factors In-Pharma